Comment on "a machine learning model for predicting the lymph node metastasis of early gastric cancer not meeting the endoscopic curability criteria" [0.03%]
关于“内镜下难以治愈的早期胃癌淋巴结转移的机器学习预测模型”的评论
Muhammad Irfan,Misaal Fatima,Maryam Shehzadi
Muhammad Irfan
Comment on "Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study" [0.03%]
关于“钠-葡萄糖共转运蛋白-2抑制剂在2型糖尿病患者中新发胃癌和胃病的有效性比较：基于人口的队列研究”的评论
Kuan-Fu Liao,Shih-Wei Lai
Kuan-Fu Liao
Antibody-drug conjugates in gastric cancer: from molecular landscape to clinical strategies [0.03%]
抗体偶联药物在胃癌中的应用：从分子图谱到临床策略
Jia-Lin Hao,Xin-Yun Li,Yu-Tong Liu et al.
Jia-Lin Hao et al.
Antibody-drug conjugates (ADCs) represent a crucial component of targeted therapies in gastric cancer, potentially altering traditional treatment paradigms. Many ADCs have entered rigorous clinical trials based on biological theories and pr...
Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma [0.03%]
局部晚期不可切除或转移性胃或胃食管交界处腺癌患者肿瘤中 Claudin 18 第 2 型同种型的全球流行率
Kohei Shitara,Rui-Hua Xu,Jaffer A Ajani et al.
Kohei Shitara et al.
Background: Limited data exist for global prevalence of claudin 18 isoform 2 (CLDN18.2) positivity and association of CLDN18.2 status with clinical and tumor characteristics in patients with locally advanced (LA) unresect...
An artificial intelligence system for comprehensive pathologic outcome prediction in early gastric cancer through endoscopic image analysis (with video) [0.03%]
基于内镜图像分析的早期胃癌综合病理结局预测人工智能系统（附视频）
Seunghan Lee,Jiwoon Jeon,Jinbae Park et al.
Seunghan Lee et al.
Background: Accurate prediction of pathologic results for early gastric cancer (EGC) based on endoscopic findings is essential in deciding between endoscopic and surgical resection. This study aimed to develop an artifici...
Outcomes after gastrectomy according to the Gastrectomy Complications Consensus Group (GCCG) in the Dutch Upper GI Cancer Audit (DUCA) [0.03%]
荷兰上消化道癌症审计(DUCA)胃切除术后结果的胃切除术后并发症共识小组(GCCG)分类
Maurits R Visser,Daan M Voeten,Suzanne S Gisbertz et al.
Maurits R Visser et al.
Background: In 2019, the Gastrectomy Complications Consensus Group (GCCG) published a standardized set of complications aiming toward uniform reporting of post-gastrectomy complications. This study aimed to report outcome...
The extracellular matrix protein EMILIN-1 impacts on the microenvironment by hampering gastric cancer development and progression [0.03%]
胞外基质蛋白EMILIN-1通过阻碍胃癌的发生发展影响肿瘤微环境
Alessandra Capuano,Maddalena Vescovo,Simone Canesi et al.
Alessandra Capuano et al.
Background: The contribution of the tumor microenvironment and extracellular matrix to the aggressive biology of Gastric Cancer (GC) has been recently characterized; however, the role of EMILIN-1 in this context is unknow...
A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of H. pylori-naïve gastric neoplasms [0.03%]
用于检测 Hp初治胃肿瘤的内镜筛查策略的数学模拟模型
Fumiaki Ishibashi,Kosuke Okusa,Yoshitaka Tokai et al.
Fumiaki Ishibashi et al.
Background: The effectiveness of esophagogastroduodenoscopy (EGD) screening in cohorts with low Helicobacter pylori prevalence is unknown. This study aimed to develop an optimally efficient EGD screening strategy for dete...
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair [0.03%]
微卫星不稳定高的胃癌及其错配修复缺陷的高效治疗策略
Akira Ooki,Hiroki Osumi,Koichiro Yoshino et al.
Akira Ooki et al.
Gastric cancer (GC) is a common malignancy that presents challenges in patient care worldwide. The mismatch repair (MMR) system is a highly conserved DNA repair mechanism that protects genome integrity during replication. Deficient MMR (dMM...
Discontinuation of neoadjuvant therapy does not influence postoperative short-term outcomes in elderly patients (≥ 70 years) with resectable gastric cancer: a population-based study from the dutch upper gastrointestinal cancer audit (DUCA) data [0.03%]
新辅助治疗中断不会影响可切除胃癌老年患者（≥70岁）术后短期结局：来自荷兰上消化道癌症审计（DUCA）数据库的队列研究
Jingpu Wang,Zhouqiao Wu,Eline M de Groot et al.
Jingpu Wang et al.
Background: For the elderly patients with gastric cancer, it may be more challenging to tolerate complete neoadjuvant therapy (NAT). The impact of discontinued NAT on the surgical safety and pathological outcomes of elder...